Benefit of splenectomy in distal pancreatectomy for neuroendocrine tumours: multicentre retrospective study.

IF 3.5 3区 医学 Q1 SURGERY
BJS Open Pub Date : 2025-05-07 DOI:10.1093/bjsopen/zraf038
Elise Clément, Pietro Addeo, Alain Sauvanet, Célia Turco, Ugo Marchese, Safi Dokmak, Christophe Laurent, Ahmet Ayav, Olivier Turrini, Laurent Sulpice, Régis Souche, Julie Perinel, David J Birnbaum, Olivier Facy, Johan Gagnière, Lilian Schwarz, Guillaume Piessen, Nicolas Regenet, Antonio Iannelli, Jean Marc Regimbeau, Xavier Lenne, Bruno Heyd, Sébastien Gaujoux, Mehdi El Amrani, Alexandre Doussot
{"title":"Benefit of splenectomy in distal pancreatectomy for neuroendocrine tumours: multicentre retrospective study.","authors":"Elise Clément, Pietro Addeo, Alain Sauvanet, Célia Turco, Ugo Marchese, Safi Dokmak, Christophe Laurent, Ahmet Ayav, Olivier Turrini, Laurent Sulpice, Régis Souche, Julie Perinel, David J Birnbaum, Olivier Facy, Johan Gagnière, Lilian Schwarz, Guillaume Piessen, Nicolas Regenet, Antonio Iannelli, Jean Marc Regimbeau, Xavier Lenne, Bruno Heyd, Sébastien Gaujoux, Mehdi El Amrani, Alexandre Doussot","doi":"10.1093/bjsopen/zraf038","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Distal pancreatectomy is frequently indicated for left-sided pancreatic neuroendocrine tumour (NET). When combined lymphadenectomy is warranted, distal pancreatectomy with splenectomy (DPS) is generally advocated to optimize lymph node dissection. The spleen-preserving distal pancreatectomy (SPDP) may represent an alternative approach. This study aimed to evaluate postoperative and oncological results of distal pancreatectomy with and without splenectomy for pancreatic NET.</p><p><strong>Methods: </strong>This multicentre retrospective study included all distal pancreatectomy for pancreatic NET performed between 2014 and 2018. Patients with functional NET or multiple endocrine neoplasia type 1 were excluded. Indications and results were compared between DPS, distal pancreatectomy according to Kimura (K-SPDP) and distal pancreatectomy according to Warshaw (W-SPDP), before and after propensity score matching (PSM).</p><p><strong>Results: </strong>Among 251 patients included (108 DPS (43%), 73 K-SPDP (29%), and 70 W-SPDP (28%)), there was no difference in terms of patients' characteristics, surgical approach, and conversion. Tumour size (P = 0.005), grade (P < 0.001) and the number of nodes analysed (P < 0.001) were significantly lower in patients undergoing K-SPDP as compared to W-SPDP or DPS. Apart from a difference in readmission rate (P = 0.002), there was no difference in terms of mortality rate or severe morbidity rate between the three techniques. After PSM comparing DPS (n = 70) and W-SPDP (n = 70), there was no difference in morbidity and mortality rates. R0 resection rate (91% versus 97%; P = 0.165), the number of nodes analysed (8 versus 7; P = 0.495), and median overall survival (P = 0.493) were not different.</p><p><strong>Conclusion: </strong>In cases of distal pancreatectomy for NET, splenectomy did not seem to improve lymph node dissection or survival. When lymph node dissection associated with distal pancreatectomy is justified, the benefit of splenectomy appears questionable.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 3","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12070039/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJS Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bjsopen/zraf038","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Distal pancreatectomy is frequently indicated for left-sided pancreatic neuroendocrine tumour (NET). When combined lymphadenectomy is warranted, distal pancreatectomy with splenectomy (DPS) is generally advocated to optimize lymph node dissection. The spleen-preserving distal pancreatectomy (SPDP) may represent an alternative approach. This study aimed to evaluate postoperative and oncological results of distal pancreatectomy with and without splenectomy for pancreatic NET.

Methods: This multicentre retrospective study included all distal pancreatectomy for pancreatic NET performed between 2014 and 2018. Patients with functional NET or multiple endocrine neoplasia type 1 were excluded. Indications and results were compared between DPS, distal pancreatectomy according to Kimura (K-SPDP) and distal pancreatectomy according to Warshaw (W-SPDP), before and after propensity score matching (PSM).

Results: Among 251 patients included (108 DPS (43%), 73 K-SPDP (29%), and 70 W-SPDP (28%)), there was no difference in terms of patients' characteristics, surgical approach, and conversion. Tumour size (P = 0.005), grade (P < 0.001) and the number of nodes analysed (P < 0.001) were significantly lower in patients undergoing K-SPDP as compared to W-SPDP or DPS. Apart from a difference in readmission rate (P = 0.002), there was no difference in terms of mortality rate or severe morbidity rate between the three techniques. After PSM comparing DPS (n = 70) and W-SPDP (n = 70), there was no difference in morbidity and mortality rates. R0 resection rate (91% versus 97%; P = 0.165), the number of nodes analysed (8 versus 7; P = 0.495), and median overall survival (P = 0.493) were not different.

Conclusion: In cases of distal pancreatectomy for NET, splenectomy did not seem to improve lymph node dissection or survival. When lymph node dissection associated with distal pancreatectomy is justified, the benefit of splenectomy appears questionable.

脾切除术在胰远端切除术治疗神经内分泌肿瘤中的益处:多中心回顾性研究。
背景:远端胰腺切除术常用于左侧胰腺神经内分泌肿瘤(NET)。当需要联合淋巴结切除术时,通常提倡远端胰切除术联合脾切除术(DPS)来优化淋巴结清扫。保留脾的远端胰腺切除术(SPDP)可能是另一种方法。本研究的目的是评估胰腺NET的远端胰腺切除术合并脾切除术和不合并脾切除术的术后和肿瘤学结果。方法:这项多中心回顾性研究包括2014年至2018年期间进行的所有胰NET远端胰腺切除术。排除功能性NET或多发性1型内分泌肿瘤患者。比较倾向评分匹配(PSM)前后DPS、Kimura远端胰腺切除术(K-SPDP)和Warshaw远端胰腺切除术(W-SPDP)的适应症和结果。结果:251例患者(DPS 108例(43%),K-SPDP 73例(29%),W-SPDP 70例(28%)),在患者特征、手术入路和转归方面无差异。与W-SPDP或DPS相比,K-SPDP患者的肿瘤大小(P = 0.005)、分级(P < 0.001)和分析的淋巴结数量(P < 0.001)均显著降低。除了再入院率差异(P = 0.002)外,三种技术在死亡率和严重发病率方面没有差异。经PSM比较DPS (n = 70)和W-SPDP (n = 70)后,发病率和死亡率无差异。R0切除率(91% vs 97%;P = 0.165),分析的节点数(8 vs 7;P = 0.495),中位总生存期(P = 0.493)无差异。结论:在NET的远端胰腺切除术病例中,脾切除术似乎并没有改善淋巴结清扫或生存率。当淋巴结清扫与远端胰腺切除术是合理的,脾切除术的好处似乎值得怀疑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BJS Open
BJS Open SURGERY-
CiteScore
6.00
自引率
3.20%
发文量
144
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信